It integrates information about VLDL, IDL, and LDL particle number into a single measurement, providing a comprehensive picture of atherogenic particle burden
Patients often assume switching from semaglutide or tirzepatide to peptide blends is a simple medication change
Phentermine should not be used with MAO inhibitors and requires caution with other stimulants and serotonergic agents (including some SSRIs)
7 Change from baseline in adipokines at Week 48
Serious Risks Less common but important: Pancreatitis Kidney problems Gallbladder issues Low blood sugar (especially in diabetics) Thyroid tumor warning (boxed FDA warning) Because tirzepatide is newer, long-term effects are still being studied
Healthcare providers should assess for signs of gallbladder disease, pancreatitis, or other serious complications throughout treatment